Private markets have a liquidity problem. Not a deal flow problem. I asked active investors what their #1 frustration is. 52% said the same thing: getting out of deals. The capital is there. The exit confidence isn’t.

Australian life sciences companies have delivered portfolio-changing returns over 24 months. $TLX: $4B+ $NEU: $2.4B+ $4DX: $2.7B AI will compress drug discovery timelines. Regulatory pathways are clearing. Capital is rotating back to real science. This is structural.

Just discovered a small hack with Claude. Ask it to produce a document for you and give it your brand colours and fonts. Next minute, a perfectly formatted document arrives

44% of investors are drowning in noise. 77% say "Management Track Record" is their #1 engagement signal. The top 3 trust markers from our 2026 Venture Capital investor survey: 1) Management Track Record (76.9%) 2) Commercial Traction (56.4%) 3) Moat (55.1%)

The best thing about working with a lot of life science and medical device companies is that you get very excited about the future of innovation in space. The scary part is learning about all the current problems across hospitals, diagnostics, surgery, processes etc.

The creepiest thing on LinkedIn has to be when people send you videos of themselves in the DMs, as an introductory message.

The number of times I hear people talk about wanting to take a sniper approach to raising capital. Completely missing the opportunity of what's being created with the attention economy. If you look at the number of VC, companies, and angels who have built their profiles, raised

After working out how to use Claude CoWork correctly, I am officially Claude Pilled.

Always grateful when the Australian mental switch-off, from Melbourne Cup to Australia Day, is complete

I just had a software provider that we utilise for one-off activities, increase their prices by 250%. They have no IP moat. No distribution moat. Nothing of significance that we can't get from other providers or build ourselves.

Now that the focus has shifted towards building data centres in space. It will be interesting to see what happens to interest in Nuclear energy among hyperscalers.